Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

Ulrich Jaeger; Constantine S. Tam; Peter Borchmann; Joseph P. McGuirk; Marianne Johansen; Edmund K. Waller; Samantha Jaglowski; Charalambos Andreadis; Stephen R. Foley; Jason R. Westin; Isabelle Fleury; P. Joy Ho; Stephan Mielke; Takanori Teshima; Gilles Salles; Stephen J. Schuster; Fiona He; Richard T. Maziarz; Sebastian Mayer; Shinichi Makita; Marie J. Kersten; Monalisa Ghosh; Nina Wagner-Johnston; Koji Kato; Paolo Corradini; Hideki Goto; Silvia Colicino; Abhijit Agarwal; Chiara Lobetti-Bodoni; Michael R. Bishop

doi:10.1182/bloodadvances.2021006193

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

Ulrich Jaeger, Constantine S. Tam, Peter Borchmann, Joseph P. McGuirk, Marianne Johansen, Edmund K. Waller, Samantha Jaglowski, Charalambos Andreadis, Stephen R. Foley, Jason R. Westin, Isabelle Fleury, P. Joy Ho, Stephan Mielke, Takanori Teshima, Gilles Salles, Stephen J. Schuster, Fiona He, Richard T. Maziarz, Sebastian Mayer, Shinichi MakitaMarie J. Kersten, Monalisa Ghosh, Nina Wagner-Johnston, Koji Kato, Paolo Corradini, Hideki Goto, Silvia Colicino, Abhijit Agarwal, Chiara Lobetti-Bodoni, Michael R. Bishop

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	4816-4820
Number of pages	5
Journal	Blood Advances
Volume	6
Issue number	16
DOIs	https://doi.org/10.1182/bloodadvances.2021006193
State	Published - Aug 23 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2021006193

Cite this

Jaeger, U., Tam, C. S., Borchmann, P., McGuirk, J. P., Johansen, M., Waller, E. K., Jaglowski, S., Andreadis, C., Foley, S. R., Westin, J. R., Fleury, I., Ho, P. J., Mielke, S., Teshima, T., Salles, G., Schuster, S. J., He, F., Maziarz, R. T., Mayer, S., ... Bishop, M. R. (2022). Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood Advances, 6(16), 4816-4820. https://doi.org/10.1182/bloodadvances.2021006193

Jaeger, U, Tam, CS, Borchmann, P, McGuirk, JP, Johansen, M, Waller, EK, Jaglowski, S, Andreadis, C, Foley, SR, Westin, JR, Fleury, I, Ho, PJ, Mielke, S, Teshima, T, Salles, G, Schuster, SJ, He, F, Maziarz, RT, Mayer, S, Makita, S, Kersten, MJ, Ghosh, M, Wagner-Johnston, N, Kato, K, Corradini, P, Goto, H, Colicino, S, Agarwal, A, Lobetti-Bodoni, C & Bishop, MR 2022, 'Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma', Blood Advances, vol. 6, no. 16, pp. 4816-4820. https://doi.org/10.1182/bloodadvances.2021006193

@article{d5c32d275cf04cdfa257aca6b90322ca,

title = "Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma",

author = "Ulrich Jaeger and Tam, {Constantine S.} and Peter Borchmann and McGuirk, {Joseph P.} and Marianne Johansen and Waller, {Edmund K.} and Samantha Jaglowski and Charalambos Andreadis and Foley, {Stephen R.} and Westin, {Jason R.} and Isabelle Fleury and Ho, {P. Joy} and Stephan Mielke and Takanori Teshima and Gilles Salles and Schuster, {Stephen J.} and Fiona He and Maziarz, {Richard T.} and Sebastian Mayer and Shinichi Makita and Kersten, {Marie J.} and Monalisa Ghosh and Nina Wagner-Johnston and Koji Kato and Paolo Corradini and Hideki Goto and Silvia Colicino and Abhijit Agarwal and Chiara Lobetti-Bodoni and Bishop, {Michael R.}",

note = "Funding Information: Acknowledgments: The authors thank Jacqueline R. Ward of Health Care Consultancy Group who provided assistance with medical writing. This work was supported by Novartis Pharmaceuticals.",

year = "2022",

month = aug,

day = "23",

doi = "10.1182/bloodadvances.2021006193",

language = "English (US)",

volume = "6",

pages = "4816--4820",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "16",

}

TY - JOUR

T1 - Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

AU - Jaeger, Ulrich

AU - Tam, Constantine S.

AU - Borchmann, Peter

AU - McGuirk, Joseph P.

AU - Johansen, Marianne

AU - Waller, Edmund K.

AU - Jaglowski, Samantha

AU - Andreadis, Charalambos

AU - Foley, Stephen R.

AU - Westin, Jason R.

AU - Fleury, Isabelle

AU - Ho, P. Joy

AU - Mielke, Stephan

AU - Teshima, Takanori

AU - Salles, Gilles

AU - Schuster, Stephen J.

AU - He, Fiona

AU - Maziarz, Richard T.

AU - Mayer, Sebastian

AU - Makita, Shinichi

AU - Kersten, Marie J.

AU - Ghosh, Monalisa

AU - Wagner-Johnston, Nina

AU - Kato, Koji

AU - Corradini, Paolo

AU - Goto, Hideki

AU - Colicino, Silvia

AU - Agarwal, Abhijit

AU - Lobetti-Bodoni, Chiara

AU - Bishop, Michael R.

N1 - Funding Information: Acknowledgments: The authors thank Jacqueline R. Ward of Health Care Consultancy Group who provided assistance with medical writing. This work was supported by Novartis Pharmaceuticals.

PY - 2022/8/23

Y1 - 2022/8/23

UR - http://www.scopus.com/inward/record.url?scp=85136465627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136465627&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2021006193

DO - 10.1182/bloodadvances.2021006193

M3 - Comment/debate

C2 - 35687492

AN - SCOPUS:85136465627

SN - 2473-9529

VL - 6

SP - 4816

EP - 4820

JO - Blood Advances

JF - Blood Advances

IS - 16

ER -

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this